ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1892 • ACR Convergence 2021

    Promotion of Autoimmune Arthritis via Tryptophan Metabolism and Production of the Bacterial-Derived Tryptophan Metabolite Indole

    Brandon Trent1, Meagan Chriswell2, Widian Jubair1 and Kristine Kuhn1, 1University of Colorado Anschutz Medical Campus, Aurora, CO, 2UC Denver SOM, Denver, CO

    Background/Purpose: Significant changes in gut bacterial richness and diversity occur during the development of inflammatory arthritis, in both murine models and human patients; however, the…
  • Abstract Number: 1899 • ACR Convergence 2021

    Mortality in Patients with Sub-Optimally Treated Gout in the Veteran’s Health Administration: A National Retrospective Cohort Study

    Lindsay Helget1, Bryant England1, Punyasha Roul1, Harlan Sayles1, Alison Petro1, Tuhina Neogi2 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2Boston University School of Medicine, Boston, MA

    Background/Purpose: Patients with gout have an increased risk of mortality. Current ACR guidelines for the treatment of gout recommend a treat-to-target approach with titration of…
  • Abstract Number: 1903 • ACR Convergence 2021

    Does Limited Stair Climbing Lead to Poor Future Health? The Relationship Between Short-term Trajectories of Stair Climbing Frequency and Incident Slow Gait Speed over 1 and 2 Years in Adults with Knee Osteoarthritis

    Jason Jakiela1, Yuqing Zhang2, Dana Voinier1, Thomas Bye1, Jennifer Copson1 and Daniel White1, 1University of Delaware, Newark, DE, 2Massachusetts General Hospital, Quincy, MA

    Background/Purpose: Knee osteoarthritis (OA) is a common cause of functional limitation in older adults, and difficulty with climbing stairs is one of the first limitations…
  • Abstract Number: 1901 • ACR Convergence 2021

    Severe Foot Symptoms Are Associated with Mortality: The Johnston County Osteoarthritis Project

    Yvonne Golightly1, Carolina Alvarez1, Marian Hannan2, Lucy Gates3, Becki Cleveland4, Amanda Nelson1 and Leigh Callahan5, 1University of North Carolina at Chapel Hill, Chapel Hill, NC, 2Marcus Institute for Aging Research, Hebrew SeniorLife, Milton, MA, 3University of Southampton, Southampton, United Kingdom, 4Thurston Arthritis Research Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, 5University of North Carolina Thurston Arthritis Research Center, Chapel Hill, NC

    Background/Purpose: Foot symptoms (i.e., pain, aching, and stiffness [PAS]) are common in middle-aged to older adults and are linked to restricted physical activity, poorer physical…
  • Abstract Number: 1898 • ACR Convergence 2021

    Risk of Major Adverse Cardiovascular Events in a Large Cohort of Patients with Acute Calcium Pyrophosphate Crystal Arthritis

    Sara Tedeschi1, Weixing Huang1, Kazuki Yoshida1 and Daniel Solomon2, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Newton, MA

    Background/Purpose: Acute calcium pyrophosphate (CPP) crystal arthritis, also known as pseudogout, causes an acute inflammatory arthritis that shares clinical similarities with gout. We investigated the…
  • Abstract Number: 1895 • ACR Convergence 2021

    Achievement of Target Serum Uric Acid Among Gout Patients Treated with Long-term Urate Lowering Therapy in the ACR’s Rheumatology Informatics System for Effectiveness (RISE) Registry

    Nevin Hammam, Jing Li, Julia L Kay, Jinoos Yazdany and Gabriela Schmajuk, University of California San Francisco, San Francisco, CA

    Background/Purpose: The American College of Rheumatology’s (ACR) 2012 guidelines for the management of gout recommend using a treat-to-target (T2T) approach to lower serum uric acid…
  • Abstract Number: 1883 • ACR Convergence 2021

    Neuro-Behcet’s Disease: 20 Years Single Center Experience of Cyclophosphamide for Induction of Remission

    Pablo Vinicius da Fonseca, Henrique Ayres Mayrink Giardini,, Célio Roberto Gonçalves and Leandro Lara do Prado, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Behçet's disease (BD) is a systemic vasculitis. Neurological involvement, also known as Neuro-Behçet's disease (NBD), leads to great morbimortality. Diagnosis is challenging, since clinical…
  • Abstract Number: 1864 • ACR Convergence 2021

    18F-Fluorodeoxyglucose PET/MRI as an Alternative Hybrid Imaging Modality: Comparative Study in a Prospective, Longitudinal Cohort of Patients with Large-Vessel Vasculitis

    Ertugrul Cagri bolek1, Kaitlin Quinn2, Hugh Alessi3, Elaine Novakovich4, Mark A. Ahlman4 and Peter Grayson5, 1Vasculitis Translational Research Program, NIAMS, NIH, US, Lanham, MD, 2National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Washington, DC, 3National Institutes of Health, Bethesda, Maryland, 4National Institutes of Health, Bethesda, MD, 5National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD

    Background/Purpose: Imaging modalities play an important role in the diagnosis and management of patients with large-vessel vasculitis (LVV). Use of 18F-fluorodeoxyglucose (FDG) positron emission tomography…
  • Abstract Number: 1906 • ACR Convergence 2021

    IL-13Ra1-Mediated Signaling Regulates Age-Associated/Autoimmune B-Cell Expansion and Lupus Pathogenesis

    Danny Flores Castro1, Zhu Chen2, Sanjay Gupta3, Michela Manni3, Juan Rivera Correa3, Max Chao4, Yurii Chinenov4, Tania Pannellini5, Habib Zaghouni6, Rolf Jessberger7 and Alessandra Pernis8, 1Autoimmunity and Inflammation Program, Hospital for Special Surgery, Palisades Park, NJ, 2Department of Rheumatology and Immunology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China (People's Republic), 3Autoimmunity and Inflammation Program, Hospital for Special Surgery, New York, NY, 4David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 5Research Division and Precision Medicine Laboratory, Hospital for Special Surgery, New York, NY, 6Department of Molecular Microbiology and Immunology, University of Missouri School of Medicine, Columbia, MO, 7Institute of Physiological Chemistry, Technische Universitat, Dresden, Germany, 8Department of Medicine, Weill Cornell Medicine, New York, NY

    Background/Purpose: Age-associated B cells (ABCs) are an emerging B cell subset that aberrantly expand in SLE. ABC generation and differentiation exhibit marked sexual dimorphism and…
  • Abstract Number: 1910 • ACR Convergence 2021

    Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Trial

    Laure Gossec1, Nemanja Damjanov2, Shigeyoshi Tsuji3, Apinya Lertratanakul4, Ralph Lippe5, Jayeshkumar Patel4, Patrick Zueger6 and Kurt de Vlam7, 1Sorbonne Université; APHP, Rheumatology Department, Pitié-Salpêtrière Hospital, Paris, France, 2University of Belgrade School of Medicine, Institute of Rheumatology, Belgrade, Serbia, 3Department of Orthopaedics/Rheumatology, National Hospital Organization, Osaka Minami Medical Center, Osaka, Japan, 4AbbVie Inc., North Chicago, IL, 5AbbVie Deutschland GmbH & Co. KG, Berlin, Germany, 6AbbVie Inc., Mettawa, IL, 7Department of Rheumatology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium

    Background/Purpose: The achievement of disease control has been shown to be associated with improved prognosis in PsA, though no single measure of low disease activity…
  • Abstract Number: 1913 • ACR Convergence 2021

    Patient Perceptions of Telemedicine Use in Rheumatology Clinics During the COVID-19 Pandemic: An Analysis from the COVID-19 Global Rheumatology Alliance

    Mithu Maheswaranathan1, Bruce Miller2, Carly Harrison3, Rashmi Sinha4, Bugra Egeli5, Berk Degirmenci6, Emily Sirotich7, Rebecca Grainger8, Jonathan Hausmann9, Jean Liew10 and Yu Pei Eugenia Chock11, 1Duke University School of Medicine, Durham, NC, 2University of California San Diego School of Medicine, La Jolla, CA, 3LupusChat, Capitol Heights, MD, 4Systemic JIA Foundation, Cincinnati, OH, 5Boston Children's Hospital, Boston, MA, 6St. Elizabeth's Medical Center, Boston, MA, 7McMaster University, Hamilton, ON, Canada, 8University of Otago, Wellington, New Zealand, 9Beth Israel Deaconess Medical Center, Boston, MA, 10Boston University, Boston, MA, 11Yale School of Medicine, Greenwich, CT

    Background/Purpose: During the COVID-19 pandemic, healthcare systems rapidly expanded telemedicine to ensure continued access to care. Few studies have explored patient perceptions of the telemedicine…
  • Abstract Number: 1912 • ACR Convergence 2021

    Meteorological Variables Have Different Effect on Core Measures of Disease Activity in Patients with Rheumatoid Arthritis

    Peter Mandl1, Paul Studenic2, Farideh Alasti1, Rainer Kaltenberger3, Andreas Kerschbaumer1, Thomas Krennert3, Josef Smolen1 and Daniel Aletaha4, 1Medical University of Vienna, Vienna, Austria, 2Karolinska Institute; & Medical University of Vienna, Stockholm, Sweden, 3Central Institute for Meteorology and Geodynamics, Vienna, Austria, 4Medical University Vienna, Vienna, Austria

    Background/Purpose: The notion that weather conditions may influence the symptoms and course of rheumatic and musculoskeletal diseases goes back to ancient times. We aimed to…
  • Abstract Number: 1909 • ACR Convergence 2021

    Impact of Antimalarial Adherence on Cardiovascular Mortality Among Patients with Newly Diagnosed Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population-based Study

    Md Rashedul Hoque1, J. Antonio Avina-Zubieta2, Diane Lacaille2, Mary De Vera3, Yi Qian3, John Esdaile4 and Hui Xie5, 1Simon Fraser University, Vancouver, BC, Canada, 2Arthritis Research Canada, Richmond, BC, Canada, 3University of British Columbia, Vancouver, BC, Canada, 4Arthritis Research Canada, Vancouver, BC, Canada, 5Simon Fraser University, Burnaby, BC, Canada

    Background/Purpose: Literature has shown poor adherence to antimalarial (AM) medications in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) patients, with the percentage of adherers…
  • Abstract Number: 1904 • ACR Convergence 2021

    “Why Does My Knee Hurt After I Got My Knee Replaced?”: Evaluation of Neuropathic-like Symptoms and Objective Signs of Neuropathy Post-Knee Replacement in Patients with Knee Osteoarthritis

    Devin Driscoll1, Priyanka Ballal1, Na Wang2, Laura Frey-Law3, Cora Lewis4, Michael Nevitt5 and Tuhina Neogi1, 1Boston University School of Medicine, Boston, MA, 2Boston University, Boston, MA, 3University of Iowa, Iowa City, IA, 4University of Alabama Birmingham, Birmingham, AL, 5University of California San Francisco, Orinda, CA

    Background/Purpose: Some people with knee osteoarthritis (OA) have persistent pain post-knee replacement, but why this occurs is not fully understood. One possibility is post-surgical neuropathy.…
  • Abstract Number: 1917 • ACR Convergence 2021

    Sputum TGF-β1 Is Elevated in Subclinical and Clinically Significant Rheumatoid Arthritis-Associated Interstitial Lung Disease and Correlates with Soluble IL-6R Levels

    Timothy Wilson1, Kevin Deane2, Joyce Lee1, Christopher Collora3, Marie Feser3, Mariana Kaplan4, Joshua Solomon5 and Kristen Demoruelle6, 1University of Colorado, Denver, CO, 2University of Colorado Denver, Denver, CO, 3University of Colorado Denver, Aurora, CO, 4National Institutes of Health, Bethesda, MD, 5National Jewish Health, Denver, CO, 6University of Colorado Anschutz Medical Campus, Aurora, CO

    Background/Purpose: Increased levels of transforming growth factor β1 (TGF-β1) in the lung have been implicated in the pathogenesis of several fibrotic lung diseases, but their…
  • « Previous Page
  • 1
  • …
  • 710
  • 711
  • 712
  • 713
  • 714
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology